Born in Kibbutz Hazor, Prof. Ido Amit earned his PhD in biological regulation at the Weizmann Institute of Science in 2007. He conducted a four-year postdoctoral fellowship at the Broad Institute of Harvard University and the Massachusetts Institute of Technology, before joining the Weizmann Institute in 2011. He is the incumbent of the Eden and Steven Romick Professorial Chair.
Prof. Amit is a pioneer in the fields of single-cell genomics and sophisticated big-data analytics. He has spearheaded the application of these technologies to generate a comprehensive atlas of the entire immune system. Prof. Amit’s research addresses some of the most fundamental questions in immunology. His discoveries are enabling the development of new immunotherapy strategies,—translational science that is poised to drive innovation in targeted immunotherapy for autoimmune disorders, neurodegenerative diseases, and cancer. In addition, Prof. Amit is renowned in the science community as a leader in immunogenomics, a new field aimed at detecting and engineering genetic sequences that are essential for immune system function in health and disease.
Prof. Amit is therecipient of numerous awards for academic and scientific excellence, and was , most recently, appointed an International Research Scholar of the Howard Hughes Medical Institute (2017).He is also the recipient of the EMBO Gold Medal Award (2016), the Helen and Martin Kimmel Award for Innovative Investigation (2016), and the Rappaport Prize (2016) for his work in revealing the function of the immune system.
Prof. Amit enjoys hiking and spending time with his family, as well as road and mountain biking.